Market News Archives

Taleb, Citrini and the Birth of the AI Scare Trade – ( $NVDA $DIA $QQQ $SPY )

by John F. Heerdink, Jr. February 24, 2026 505Views 0Likes

Taleb, Citrini and the Birth of the AI Scare Trade Nassim Nicholas Taleb and Citrini Research have unintentionally become co-authors of Wall Street’s latest genre: the AI scare trade, where investors hedge against the possibility that the very technology powering the boom becomes…

February 23, 2026- Dow Sinks 800 Points as Tariffs and AI “Scare Trade” Rattle Wall Street -( $GOVX $INTG $MCD Rise!)

by John F. Heerdink, Jr. February 23, 2026 1056Views 0Likes

U.S. stocks sold off sharply on Monday as fresh tariff uncertainty from Washington and mounting concerns over AI-driven disruption sparked a broad risk-off move across Wall Street, driving a roughly 800‑point slide in the Dow and sending the S&P 500 and Nasdaq…

Gene Editing’s Next Act: How A Nobel Laureate Wants To Turn CRISPR From Hype To Habit

by John F. Heerdink, Jr. February 23, 2026 428Views 0Likes

In an era when artificial intelligence has stolen most of biotech’s buzz, gene editing is quietly trying to grow up from scientific marvel to dependable business line. At the center of that transition stands Nobel laureate Jennifer Doudna, who is now pairing…

Gilead’s $7.8 Billion Bet on Arcellx: When CAR‑T Goes Prime Time for Multiple Myeloma -( $ACLX $GLD $XBI $IBB )

by John F. Heerdink, Jr. February 23, 2026 521Views 0Likes

Gilead Sciences (GLD) is paying up to $7.8 billion to acquire Arcellx (ACLX) , a longtime cell‑therapy partner, in a bid to turn a promising collaboration into a franchise‑defining pillar. Under the definitive agreement, Arcellx shareholders receive $115 per share in…

Google Buys Its Own Sunshine: Inside the $4.75 Billion Intersect Power Deal -( $GOOG $GOOGL )

by John F. Heerdink, Jr. February 23, 2026 499Views 0Likes

Alphabet’s decision to acquire Intersect Power for roughly $4.75 billion is less a vanity green purchase and more a hard‑nosed bet that the next edge in artificial intelligence will be measured in megawatts as much as in model parameters. In one stroke,…

Varda Space Aims to Turn Low Earth Orbit into Pharma’s New Production Line

by John F. Heerdink, Jr. February 23, 2026 523Views 0Likes

The new space economy is quietly adding an unexpected aisle to the drugstore: a “made‑in‑orbit” shelf where tomorrow’s pills may be grown, not in stainless-steel vats, but in microgravity factories looping Earth at Mach 25. Yes one day, your doctor’s prescription may…

Eupraxia’s Latest Raise: A Diffusphere-Fueled War Chest Aims at GI Disease -( $EPRX $IBB $XBI $SNY)

by John F. Heerdink, Jr. February 21, 2026 480Views 0Likes

In a market that has grown wary of “story stocks,” Eupraxia Pharmaceuticals (NASDAQ: EPRX) just delivered something refreshingly old-fashioned: a fully closed, upsized equity offering that actually funds a clinical plan rather than a marketing slogan. The clinical‑stage biotech, which trades on…

February 20, 2026- Tariffs, Tantrums, and a 1.1% Gain: Wall Street’s Surprisingly Chill Week -( $EPRX $NOK $NVDA $OPEN Rise!)

by John F. Heerdink, Jr. February 21, 2026 985Views 0Likes

US stocks finished the holiday‑shortened week ended Friday, February 20, 2026 higher, as a landmark Supreme Court decision scrapping President Trump’s emergency “Liberation Day” tariffs overshadowed softer growth data and firmer inflation readings.finance. Index performance S&P 500: up about 0.7% on Friday…

Earnings, Algorithms, PCE and Iran: What Could Possibly Go Wrong? -( $DIA $QQQ $SPY $VIX )

by John F. Heerdink, Jr. February 20, 2026 494Views 0Likes

Wall Street closed Thursday walking a now-familiar tightrope: cheering resilient earnings and AI-fueled innovation while eyeing rising US-Iran tensions and a looming inflation check that could jostle the Federal Reserve’s carefully choreographed exit from peak rates. Futures Lean Green As Geopolitics Heat…

February 19, 2026- Soft Landing, Hard Reality: What Today’s Sell‑Off Is Whispering to Patient Investors -( $DV $INTG $MODD $MTWO $NOK $OPEN $SER $VIX Rise!)

by John F. Heerdink, Jr. February 19, 2026 1009Views 0Likes

U.S. stocks traded lower on Thursday, with major indexes pulling back after recent gains as investors digested Walmart earnings, a heavy data calendar, and still‑hawkish Fed signals. Indexes and macro The Dow Jones Industrial Average fell about 0.54% to roughly 49,395.16, while…

Market News

Your Guide To Staying Informed In The Markets